Clinical Trial: A real-world study of first-line maintenance therapy with senaparib in newly diagnosed advanced epithelial ovarian, primary peritoneal, or fallopian tube cancer (China)

China, Sept. 15 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A real-world study of first-line maintenance therapy with senaparib in newly diagnosed advanced epithelial ovarian, primary peritoneal, or fallopian tube cancer'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132467

Registration Time: 2026/09/15

Type: Observational study

Primary Sponsor: JIANGSU CANCER HOSPITAL

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=335748

Published by HT Digital Content Services with permission from Health Daily Digest....